
March 4th: MIT Sloan HSI Lunch Seminar Series Scale Up Event Series Part 3- Healthcare Talent Imperative
E62-450
100 Main Street, Cambridge, MA United States
Registration
Details
Bringing together healthcare leaders with lenses covering health technology, Pharma and Med Tech
Speakers:
Liam Hurley - Spencer Stuart
Anders Tveteraas - Novartis
Carolyn Kelley - Philips
Moderators:
Rebecca L. Schechter, MBA, Formerly at Nuance/Microsoft, Healthcare executive and CEO
Eric Berger, MBA '11, Partner, Bain & Company
Location: E62-450
Time: 11:30am - 1pm
RSVP at Sloan Groups *Open to All*
Lunch will be provided in person.
Join Zoom Meeting
Representing Digital in Pharma: Anders Tveteraas
VP @ Novartis, leading all int'l digital and patient facing activities
VP @ Novartis, leading all int'l digital and patient facing activities
Representing Talent Leadership in MedTech: Carolyn Kelley
Vice President, People Business Partner Connected Care, Philips
Prior to joining Philips, she was the Executive Director, HR Business Partner, for Bristol Myers Squibb’s Cell Therapy and Development Operations Organization. Prior to this, Carolyn was the Vice President of Talent Management for Saint-Gobain in North America. Carolyn started her professional career as an Industrial Engineer at Intel and after 12 years in various technical and management roles within Intel moved to the People Function.
Passionate about patients, technology, and people, Carolyn has a broad experience in People Business Partnering, Talent Development, Engineering, and Operations.
She holds a bachelor’s degree in industrial engineering from Rochester Institute of Technology.
Representing Exec search across Healthcare Technology: Liam Hurley
Partner, Spencer Stuart TMT & CEO practices
An experienced corporate governance and talent adviser, Liam Hurley is a consultant and member of Spencer Stuart’s Technology, Media & Telecommunications and Board practices. Liam has conducted C-level and board director search assignments for many of the technology industry’s leading publicly traded and private equity-backed companies. In addition, Liam has expertise in public company board practices and global corporate governance trends and has extensive experience advising technology companies on board and C-suite succession.
Liam earned a bachelor’s degree in English from Connecticut College and an MBA from The American University. He has published extensively on a variety of technology and corporate governance issues, including enterprise risk management, cybersecurity, diversity, board composition, board evaluation and strategy oversight.
Speakers

Liam Hurley
Partner, Spencer Stuart TMT & CEO practices
Spencer Stuart
https://www.linkedin.com/in/liamhurley/
An experienced corporate governance and talent adviser, Liam Hurley is a consultant and member of Spencer Stuart’s Technology, Media & Telecommunications and Board practices. Liam has conducted C-level and board director search assignments for many of the technology industry’s leading publicly traded and private equity-backed companies. In addition, Liam has expertise in public company board practices and global corporate governance trends and has extensive experience advising technology companies on board and C-suite succession.

Anders Tveteraas
Int'l Head, Patient Solutions & Services
Novartis
https://www.linkedin.com/in/anders-tveteraas-a1806a1/

Carolyn Kelley
VP, People Partner, Monitoring and Sleep and Respiratory Care
Philips
https://www.linkedin.com/in/carolyn-kelley-92a86510/

Rebecca L. Schechter, MBA
Healthcare executive and CEO
Formerly at Nuance/Microsoft
https://www.linkedin.com/in/rebecca-schechter/
With over 25 years of experience in building and transforming businesses at scale across healthcare and financial services, she is a passionate end to end P&L leader/CEO having led business with revenue of $250M to $6B., investor, and advisor who leverages technology to improve outcomes for all.
Most recently, as the SVP and General Manager of DAX, Nuance's market-leading healthcare GenAI SaaS solution, she led a team of talented professionals committed to transforming the clinician-patient experience with the latest advancements in conversational AI, ambient intelligence, and generative AI. Prior to that, she was the CEO of Optum Behavioral Health and held President and C-Suite roles at Liberty Mutual and State Street.
She is a Board Director at iA Financial Group, where she contributes to the risk, governance, and ethics oversight of one of Canada's largest insurance and wealth management companies. As a Venture Partner at Nina Capital, a global healthtech venture fund, she supports early-stage startups that are developing cutting-edge solutions in digital health, medtech, biotech, and wellness. She is also an advisor to global Private Equity Investors in healthcare/technology.
Her core competencies include driving transformative plays at scale, delivering profitable growth with a proven track record in highly competitive and regulated markets. She has an MBA from MIT Sloan, and has lived, worked and studied across Europe, North America and Asia.

Eric Berger
Partner
Bain & Company
https://www.linkedin.com/in/eric-berger-48367215/
Eric Berger is a member of Bain’s Healthcare & Life Sciences and Private Equity practices with more than 10 years of consulting experience.
Eric advises clients across a range of industries, with a focus in private equity funds as well as healthcare payers and services and biotech / pharma. He has additional experience in industrial goods and services and consumer packaged goods.
He holds expertise in topics related to commercial due diligence, business unit strategy, operating model, organization design, pricing, brand strategy and mergers & acquisitions.
Prior to joining Bain in 2011, Eric worked for a small consulting firm in Boston focused on the pharmaceutical, biotech and medical device industries. Previously, he was a researcher in organic chemistry at Harvard University. Eric has published in Science and the Journal of the American Chemical Society and was awarded a grant from the Howard Hughes Medical Institute and the Jean Dreyfus Boissevain scholarship.
Eric earned an MBA from MIT Sloan School of Management. He holds a BA cum laude and MA in chemistry from Harvard University.

Anne Quaadgras
Director
MIT Sloan Health Systems Initiative
https://www.linkedin.com/in/anne-quaadgras-6208778/
Anne Quaadgras is the Director of the MIT Sloan Health Systems Initiative and a Senior Lecturer at MIT Sloan.
Her work focuses on health systems transformation, and the role of information technology in supporting that change.
Prior to her doctoral work, Anne was a management consultant for fifteen years, specializing in improving decision-making and investment processes in the chemical, pharmaceutical, and financial services industries.
She holds a Bachelor’s and Master’s degree in chemical engineering from MIT. Anne earned her doctorate in information systems at Boston University, where her dissertation research explored how globally distributed groups of experts recognize and respond to operational problems.